Fleishman-Hillard Clinical Trials Division and Provisio Inc. Announce Strategic Partnership

Strategic partnership aligns iTrials patient recruitment technologies with services offered by Fleishman-Hillards Clinical Trials Division.

St. Louis / Nashville,(PRWEB) January 10, 2005 -- Fleishman-Hillard International Communications and Provisio, Inc., today announced a strategic partnership that will align Provisios iTrials proprietary patient recruitment technology platform with the portfolio of patient recruitment services offered by Fleishman-Hillards Clinical Trials Division. The agreement formalizes the two companies ongoing collaboration to serve clients and pursue new opportunities.

The combination of Provisios iTrials software partnered with Fleishman-Hillards proven clinical trial recruitment strategies offers our clients a powerful tool for meeting or exceeding their recruitment goals," said Fleishman-Hillard Senior Vice President and Senior Partner Anne St. Peter, who is general manager of the firms Kansas City office and co-chair of its global biotechnology and health care practice group. We have already demonstrated our ability to work closely and effectively with the Provisio team. We look forward to taking that teamwork to a new level with this partnership."

Provisio, Inc., developer and owner of the iTrials proprietary information management platform for clinical trial recruitment, provides services that accelerate patient recruitment for the pharmaceutical and biotechnology industries, as well as for academic research organizations. With iTrials, we bring together advanced data analysis, security, and communications technologies, a workflow that includes collaboration and referrals by physicians, and records on tens of millions of eligible candidates, which we have gathered in full compliance with HIPAA patient confidentiality requirements," said Mike Hassell, chief executive officer of Provisio, Inc. It all adds up to a powerful enrollment service that changes the paradigm for initiating clinical trials."

The Fleishman-Hillard Clinical Trials Division has successfully recruited patients for clinical trials in a variety of therapeutic areas. The Clinical Trials Division is managed by a diverse range of experts who are ready to execute global trials anywhere in the world with clinical trial centers based in Kansas City, Boston, Cleveland, Research Triangle Park, San Francisco, Toronto, London, Frankfurt, and Tokyo.

Fleishman-Hillard Inc., one of the worlds leading public relations firms, has built its reputation on using strategic communications to deliver what its clients value most: meaningful, positive, and measurable impact on the performance of their organizations. The firm is widely recognized for excellent client service and a strong company culture founded on teamwork, integrity, and personal commitment. Based in St. Louis, the firm operates throughout North America, Europe, Asia, Latin America, Australia, and South Africa through its 83 owned offices. For more information, visit the Fleishman-Hillard Web site at www.fleishman.com.

Fleishman-Hillard is a part of Omnicom Group Inc. (NYSE: OMC). Omnicom is a leading global advertising, marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, direct and promotional marketing, public relations, and other specialty communications services to over 5,000 clients in more than 100 countries.

Nashville-based Provisio, Inc. is a steward of partnered healthcare data and developer of proprietary information technologies to drive innovation in research and marketing for drugs and medical devices. Provisios flagship HIPAA-conforming solution, iTrials, provides critical information for study modeling and employs a physician-centric model to dramatically speed recruitment and enrollment in clinical trials. Visit www.iTrials.com or contact Mike Hassell, CEO, (615) 279-3405.

# # #